We are live on ! Find out more

1,440 hedge funds and large institutions have $72.8B invested in Cigna in 2022 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 504 increasing their positions, 488 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 75

71% more funds holding in top 10

Funds holding in top 10: 3153 (+22)

62% more call options, than puts

Call options by funds: $2.1B | Put options by funds: $1.3B

10% more capital invested

Capital invested by funds: $66.4B → $72.8B (+$6.44B)

5% more funds holding

Funds holding: 1,3751,440 (+65)

3% more repeat investments, than reductions

Existing positions increased: 504 | Existing positions reduced: 488

0.04% more ownership

Funds ownership: 87.07%87.12% (+0.04%)

Holders
1,440
Holders Change
+65
Holders Change %
+4.73%
% of All Funds
24.26%
Holding in Top 10
53
Holding in Top 10 Change
+22
Holding in Top 10 Change %
+70.97%
% of All Funds
0.89%
New
161
Increased
504
Reduced
488
Closed
75
Calls
$2.1B
Puts
$1.3B
Net Calls
+$804M
Net Calls Change
-$146M
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$566M -$4.53M -17,580 -0.8%
Amundi
27
Amundi
France
$564M +$38.8M +150,412 +8%
GCM
28
Glenview Capital Management
New York
$547M +$124M +480,192 +30%
Charles Schwab
29
Charles Schwab
California
$483M +$6.15M +23,849 +1%
PI
30
Putnam Investments
Massachusetts
$452M +$408M +1,581,517 +1,189%
Swedbank
31
Swedbank
Sweden
$418M -$34.9M -135,290 -8%
Deutsche Bank
32
Deutsche Bank
Germany
$414M -$49.6M -192,321 -11%
UBS AM
33
UBS AM
Illinois
$398M -$33.1M -128,384 -8%
Goldman Sachs
34
Goldman Sachs
New York
$384M +$113M +437,915 +43%
Sumitomo Mitsui Trust Group
35
Sumitomo Mitsui Trust Group
Japan
$368M +$99.3M +385,525 +38%
Swiss National Bank
36
Swiss National Bank
Switzerland
$367M -$11.1M -43,200 -3%
Parallax Volatility Advisers
37
Parallax Volatility Advisers
California
$366M +$105M +407,018 +41%
Citadel Advisors
38
Citadel Advisors
Florida
$349M -$10.7M -41,668 -3%
Marshall Wace
39
Marshall Wace
United Kingdom
$340M +$294M +1,141,865 +772%
AllianceBernstein
40
AllianceBernstein
Tennessee
$310M +$3.9M +15,153 +1%
LAM
41
Lyrical Asset Management
New York
$301M -$16.7M -64,802 -5%
RL
42
Ruffer LLP
United Kingdom
$297M -$117M -455,733 -29%
Millennium Management
43
Millennium Management
New York
$280M +$37.7M +146,238 +16%
Barclays
44
Barclays
United Kingdom
$270M -$16.7M -64,910 -6%
Russell Investments Group
45
Russell Investments Group
United Kingdom
$248M +$17.9M +69,304 +8%
American Century Companies
46
American Century Companies
Missouri
$231M +$82.5M +320,153 +58%
Neuberger Berman Group
47
Neuberger Berman Group
New York
$217M -$7.09M -27,499 -3%
AIM
48
Artemis Investment Management
United Kingdom
$215M +$209M +812,783 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$213M -$10.8M -41,924 -5%
Fidelity International
50
Fidelity International
Bermuda
$211M -$2.53M -9,805 -1%

CI Hedge Fund Activity: Q2 2022 in Review

1,440 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cigna (CI) for Q2 2022, worth a combined $72.8B — up 9.7% from $66.4B a quarter earlier.

Buyers outnumbered sellers: 161 funds opened new CI positions and 75 closed out — a net gain of 86 holders — while 504 added to existing stakes and 488 trimmed.

The largest buyer was Putnam Investments, adding an estimated $408M. The largest seller was T. Rowe Price Associates, cutting an estimated $477M.

  • 1,440 institutional investors held Cigna (CI) as of Q2 2022, up from 1,375 in Q1 2022.
  • Funds reported $72.8B of Cigna stock for Q2 2022, up 9.7% quarter-over-quarter.
  • 161 funds opened new Cigna positions in Q2 2022 and 75 closed out, a net change of +86 holders.
  • The largest Cigna buyer in Q2 2022 was Putnam Investments, an estimated $408M added.
  • The largest Cigna seller in Q2 2022 was T. Rowe Price Associates, an estimated $477M sold.

Based on aggregated 13F filings for Q2 2022.